WebApr 11, 2024 · Objective: The important effect modifiers of high disease severity on the relationship between the different volumes of early fluid resuscitation and prognosis in septic patients are unknown. Thus, this study was designed to assess whether the efficacy of different volumes in the early fluid resuscitation treatment of sepsis is affected by … WebSep 2, 2014 · In the 520 patients who had high-extent disease, treatment with ADT plus docetaxel had a median overall survival of 49.2 months versus 32.2 in the ADT-only group — a difference of 17 months.
Prognostic Value of the LATITUDE and CHAARTED Risk Criteria
WebApr 12, 2024 · Docetaxel plus ADT should be offered to patients with metastatic noncastrate prostate cancer with high-volume disease (four or more bone metastases, one or more of … Symptoms of hypervolemia range in severity for each person and could include: 1. Swellingin an area of your body, most often your arms and legs, where it appears … See more Several factors could cause hypervolemia including too much salt in your body, an underlying condition or hormonal changes. See more Your kidneys help your body remove excess fluid through your urinary system, which leaves your body as pee (urine). Your kidneys function to balance the amount … See more list of satanic churches
Management of Oligometastatic Prostate Cancer - Applied …
WebMar 2, 2024 · Summary of relative and absolute risks for mixed treatment comparisons derived from frequentist network meta-analysis using 4 levels of certainty: high (further research very unlikely to change confidence in the estimate of effect), moderate (further research likely to have important association with confidence in estimate of effect and … WebFeb 9, 2024 · PSA is a protein made by both normal and cancerous cells in your prostate. A higher PSA level in your blood is associated with an increased risk of developing prostate … WebThe CHAARTED study, which defined high-volume disease as that in which patients have either visceral metastases or 4 or more bone metastases, at least one of which is outside the vertebral column or pelvis, found that patients with high-volume disease have a worse prognosis than those with low-volume disease. imlie 22nd july 2022